Evidence map›Paper›PMID 40519384›Full record

ArticleCureus2025

Yoga as an Adjunct Intervention for Chemotherapy-Induced Peripheral Neuropathy: Evidence, Challenges, and Future Directions.

Selvaraj Giridharan, Mrunmai Godbole

Abstract readEditorial
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Selvaraj GiridharanOncology, Tawam Hospital, Al Ain, ARE.
Mrunmai GodboleYoga, Jayawant Shikshan Prasarak Mandal University, Pune, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent complication of cancer treatment that causes sensory symptoms and emotional distress that impair the quality of life (QOL). Current treatments often fall short, necessitating innovative adjunct interventions. Yoga, which combines mindful movement, breathwork, and meditation, offers a holistic approach to mitigating the physical and psychosocial burdens of CIPN. Early trials suggest that yoga may reduce pain, enhance functionality, and support psychological well-being, although they are limited by small samples and inconsistent methods. Barriers to adoption include clinician skepticism, access challenges, and various research protocols. Prioritizing large-scale standardized trials, qualitative research on patient experiences, and telehealth delivery can strengthen yoga's evidence base and accessibility. Multidisciplinary care models integrating yoga can transform CIPN management and promote patient-centered recovery in oncology.

Indexed as

chemotherapy-induced peripheral neuropathy (cipn)complementary therapyneurotoxicityquality of life (qol)yoga

Identifiers

PMID40519384
PMCPMC12165313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.